...
首页> 外文期刊>EFSA Journal >Re‐evaluation of polyglycerol polyricinoleate (E?476) as a food additive
【24h】

Re‐evaluation of polyglycerol polyricinoleate (E?476) as a food additive

机译:重新评估作为食品添加剂的聚甘油聚蓖麻油酸酯(E?476)

获取原文

摘要

The Panel on Food Additives and Nutrient Sources added to Food (ANS) provides a scientific opinion re‐evaluating the safety of polyglycerol polyricinoleate (PGPR, E 476) used as a food additive. In 1978, the Scientific Committee for Food (SCF) established an acceptable daily intake (ADI) of 7.5 mg/kg body weight (bw) per day for PGPR. PGPR is hydrolysed in the gut resulting in the liberation of free polyglycerols, polyricinoleic acid and ricinoleic acid. Di‐ and triglycerol are absorbed and excreted unchanged in the urine; long‐chain polyglycerols show lower absorption and are mainly excreted unchanged in faeces. Acute oral toxicity of PGPR is low, and short‐term and subchronic studies indicate PGPR is tolerated at high doses without adverse effects. PGPR (E 476) is not of concern with regard to genotoxicity or carcinogenicity. The single reproductive toxicity study with PGPR was limited and was not an appropriate study for deriving a health‐based guidance value. Human studies with PGPR demonstrated that there is no indication of significant adverse effect. The Panel considered a 2‐year combined chronic toxicity/carcinogenicity study for determining a reference point and derived a no observed adverse effect level (NOAEL) for PGPR (E 476) of 2,500 mg/kg bw per day, the only dose tested. Therefore, the Panel concluded that the present data set give reason to revise the ADI of 7.5 mg/kg bw per day allocated by SCF to 25 mg/kg bw per day. Exposure estimates did not exceed the ADI of 25 mg/kg bw per day and a proposed extension of use would not result in an exposure exceeding this ADI. The Panel recommended modification of the EU specifications for PGPR (E 476).
机译:食品中添加的食品添加剂和营养来源小组(ANS)提供了一种科学意见,重新评估了用作食品添加剂的聚甘油聚蓖麻油酸酯(PGPR,E 476)的安全性。 1978年,食品科学委员会(SCF)确定PGPR的每日可接受摄入量(ADI)为7.5毫克/千克体重(bw)。 PGPR在肠中水解,导致游离的聚甘油,聚蓖麻油酸和蓖麻油酸的释放。甘油和甘油被尿中的尿素吸收和排泄;长链聚甘油显示较低的吸收,并且主要以不变的方式排泄在粪便中。 PGPR的急性经口毒性较低,短期和亚慢性研究表明,高剂量耐受PGPR,无副作用。 PGPR(E 476)与遗传毒性或致癌性无关。 PGPR的单项生殖毒性研究有限,因此不适合用于得出基于健康的指导值。 PGPR的人体研究表明,没有明显的不良反应迹象。专家组考虑了一项为期2年的慢性毒性/致癌性综合研究,以确定一个参考点,得出的每日PGPR(E 476)的未观察到的不良反应水平(NOAEL)为2,500 mg / kg bw,这是唯一的测试剂量。因此,小组得出结论,目前的数据集有理由将SCF分配的每日允许摄入量7.5 mg / kg bw修改为每天25 mg / kg bw。估计接触量不超过每日25 mg / kg bw的每日允许摄入量,建议延长使用期限不会导致接触量超过该每日允许摄入量。专家小组建议修改PGPR的欧盟规范(E 476)。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号